Stock SLRX SALARIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Salarius Pharmaceuticals, Inc.

Equities

SLRX

US79400X3052

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.499 USD -1.77% Intraday chart for Salarius Pharmaceuticals, Inc. +2.93% -23.23%
Mar. 25 Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data MT
Mar. 25 Top Premarket Gainers MT

Chart calendar Salarius Pharmaceuticals, Inc.

b3347f28694199ea329c2fe380.uXbkitnv5Ko7NyMJJWtvTXbNugPYKKRvKSiWIJJFvHE.ziGz4LO8suhvcVJgYTxbdC61z1K9Y5QWGnehWeIzzD7QDJXNlpyI72RbRA~35e002e441c4347e1c0dd31392224bd9

Upcoming events on Salarius Pharmaceuticals, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2025-03-30 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Salarius Pharmaceuticals, Inc.

2024-03-22 04:05 pm Q4 2023 Earnings Release
2023-08-10 04:05 pm Q2 2023 Earnings Release
2023-07-11 Tumor Models Conference
2023-06-14 11:00 am Annual General Meeting
2023-06-07 European Hematology Association Hybrid Congress
2023-06-04 BIO International Convention
2023-05-11 08:00 am Q1 2023 Earnings Release
2023-04-19 09:00 am American Association for Cancer Research Meeting - Abstract No 6253
2023-04-16 01:30 pm American Association for Cancer Research Meeting - Abstract No 524
2023-04-05 11:00 am Diamond Equity Research Research Emerging Growth Invitational Conference
2023-03-27 08:30 am Q4 2022 Earnings Release
2023-01-25 Molecular Glue Drug Development Summit
2022-12-14 11:00 am Business Update Call
2022-12-12 American Society of Hematology Meeting - Abstract No 170138
2022-12-12 American Society of Hematology Meeting - Abstract No 167495
2022-11-10 08:30 am Q3 2022 Earnings Release
2022-10-26 05:30 pm Targeted Protein Degradation Summit
2022-10-05 American Association of Cancer Research Special Conference
2022-09-29 10:30 am Ladenburg Thalmann Healthcare Conference
2022-08-08 11:00 am Interim 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		3,47
3,32
4.37%		5,23
5,25
-0.25%		1,84
3,14
-41.3%		0,00
0,00
- 		0,00



0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00



0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-7,79
-8,04
3.11%		0,00
0,00
- 		0,00
0,00
- 		0,00



-22,1

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-12,8
-13,0
1.78%		0,00
0,00
- 		0,00



0,00

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-7,35
-7,59
3.17%		-12,8
-13,0
1.78%		-31,6
-22,3
-41.82%		-12,5



-21,9

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-12,5
-13,8
9.09%		-7,75
-7,50
-3.33%		0,00
-0,85
- 		-3,84



-26,8

Announcement Date23/03/2018/03/2110/03/2227/03/2322/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,33
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,14
-3,55
-16.92%











-5,42
-5,97
9.25%		-3,97
-4,71
15.72%		-2,53
-4,02
37%














Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,10
-3,71
-10.62%











-5,34























Net income
Million USD		Released
Forecast
Spread 		-4,10
-3,68
-11.63%		-6,11
-4,32
-41.35%		-4,72
-4,52
-4.5%		-14,4
-4,94
-191.87%		-6,37
-5,79
-10.01%		-5,34
-5,95
10.21%		-3,88
-4,69
17.26%		-2,44
-3,97
38.46%














EPS
USD		Released
Forecast
Spread 		-2,25
-2,00
-12.5%		-3,25
-2,25
-44.44%		-2,25
-2,50
10%		-6,41
-2,25
-184.89%		-2,75
-2,24
-22.77%		-2,23
-2,43
8.04%		-1,43
-1,30
-10.28%		-0,65
-1,34
51.31%
-6,70


-6,70


-6,70


-6,71


-5,85

Announcement Date10/03/2212/05/2205/08/2210/11/2227/03/2311/05/2310/08/2309/11/23-----

Upcoming sector events for Salarius Pharmaceuticals, Inc.

2024-04-26 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-28 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
2024-04-28 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-28 MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-29 04:05 pm QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-30 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Salarius Pharmaceuticals, Inc.

Today 01:00 am BB BIOTECH AG: Q1 2024 Earnings Release
Today BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
Today PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
Today HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
Today BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
Today CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 07:00 am MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
2024-04-25 02:00 am PURETECH HEALTH PLC: Q4 2023 Earnings Release
2024-04-24 FORMYCON AG: Q4 2023 Earnings Release
2024-04-24 PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SLRX Stock
  4. Calendar Salarius Pharmaceuticals, Inc.